Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jinil Han

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
Plos One|November 22, 2018
BCT score predicts chemotherapy benefit in Asian patients with hormone receptor-positive, HER2-negative, lymph node-negative breast cancerMi Jeong Kwon, Sae Byul Lee, Jinil Han, et al.
Journal of Molecular Medicine (Berlin, Germany)|February 28, 2024
The complement factor H-related protein-5 (CFHR5) exacerbates pathological bone formation in ankylosing spondylitisJi-Hyun Lee, Seung Hoon Lee, Chanhyeok Jeon, et al.
Frontiers in Oncology|August 13, 2019
Comparison of GenesWell BCT Score With Oncotype DX Recurrence Score for Risk Classification in Asian Women With Hormone Receptor-Positive, HER2-Negative Early Breast CancerMi Jeong Kwon, Jeong Eon Lee, Joon Jeong, et al.
Oncotarget|December 2, 2017
Genes co-amplified with <i>ERBB2</i> or <i>MET</i> as novel potential cancer-promoting genes in gastric cancerMi Jeong Kwon, Ryong Nam Kim, Kyoung Song, et al.
Frontiers in Oncology|March 12, 2021
Validation of the GenesWell BCT Score in Young Asian Women With HR+/HER2- Early Breast CancerMi Jeong Kwon, Jai Min Ryu, Soo Youn Cho, et al.
Breast Cancer Research and Treatment|April 15, 2017
MMP11 and CD2 as novel prognostic factors in hormone receptor-negative, HER2-positive breast cancerJinil Han, Yoon-La Choi, Haein Kim, et al.
Oncotarget|October 6, 2017
Targeted exome sequencing of Korean triple-negative breast cancer reveals homozygous deletions associated with poor prognosis of adjuvant chemotherapy-treated patientsHae Min Jeong, Ryong Nam Kim, Mi Jeong Kwon, et al.
Scientific Reports|March 29, 2017
A new molecular prognostic score for predicting the risk of distant metastasis in patients with HR+/HER2- early breast cancerGyungyub Gong, Mi Jeong Kwon, Jinil Han, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Plos One|November 22, 2018
BCT score predicts chemotherapy benefit in Asian patients with hormone receptor-positive, HER2-negative, lymph node-negative breast cancerMi Jeong Kwon, Sae Byul Lee, Jinil Han, et al.
Journal of Molecular Medicine (Berlin, Germany)|February 28, 2024
The complement factor H-related protein-5 (CFHR5) exacerbates pathological bone formation in ankylosing spondylitisJi-Hyun Lee, Seung Hoon Lee, Chanhyeok Jeon, et al.
Frontiers in Oncology|August 13, 2019
Comparison of GenesWell BCT Score With Oncotype DX Recurrence Score for Risk Classification in Asian Women With Hormone Receptor-Positive, HER2-Negative Early Breast CancerMi Jeong Kwon, Jeong Eon Lee, Joon Jeong, et al.
Oncotarget|December 2, 2017
Genes co-amplified with <i>ERBB2</i> or <i>MET</i> as novel potential cancer-promoting genes in gastric cancerMi Jeong Kwon, Ryong Nam Kim, Kyoung Song, et al.
Frontiers in Oncology|March 12, 2021
Validation of the GenesWell BCT Score in Young Asian Women With HR+/HER2- Early Breast CancerMi Jeong Kwon, Jai Min Ryu, Soo Youn Cho, et al.
Breast Cancer Research and Treatment|April 15, 2017
MMP11 and CD2 as novel prognostic factors in hormone receptor-negative, HER2-positive breast cancerJinil Han, Yoon-La Choi, Haein Kim, et al.
Oncotarget|October 6, 2017
Targeted exome sequencing of Korean triple-negative breast cancer reveals homozygous deletions associated with poor prognosis of adjuvant chemotherapy-treated patientsHae Min Jeong, Ryong Nam Kim, Mi Jeong Kwon, et al.
Scientific Reports|March 29, 2017
A new molecular prognostic score for predicting the risk of distant metastasis in patients with HR+/HER2- early breast cancerGyungyub Gong, Mi Jeong Kwon, Jinil Han, et al.
Pageof 3